NCT Number: NCT00490048
Assessment of Pulmonary Involvement inUlcerative Colitis by Induced Sputum
Ulcerative colitis is a systemic disease we assume that extra intestinal involvement as we describein our study( Fireman Z, Osipov A, Kivity S, Kopelman Y, Sternberg A Fireman E: Assessment of pulmonary involvement in Crohn's disease by induced sputum. Am J Gastroenterol 2000;95(30):730-734. )
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
Twenty Ulcerative colitis patients and 20 control subjects (all nonsmokers) without respiratory symptoms will be tested. The induce sputum by 20' inhalation of 3.5% saline using ultrasonic nebulizer. Samples will studied by differential counts of 200 cells on cytopreps stained by Giemsa. T-lymphocyte subset analyses were done by FACS using three monoclonal antibodies: CD3 = total T cells, CD4 = T helper cells, and CD8 = T suppressor-cytotoxic cells. CD4/CD8 >2.5 was considered abnormal.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- All the ulceratvive colitis patients without lung involvmentage 18-75 years of age
Exclusion criteria
- Pregnant women
- Non cooperative patients
- Smoker
- Lung disease
Treatment and study plan
Primary outcomes
-
lung involvment in Ulcerative colitis patients
Sponsors and collaborators
Lead sponsor
Hillel Yaffe Medical Center
Other Gov
Registry information
Important dates
- Study start
- 2007
- Study completion
- 2007
- First posted
- Jun 22, 2007
- Registry last updated
- Jun 22, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
NCT02914535
Colitis, Colitis, Ulcerative
Dothan, Alabama, United States
View Trial DetailsA Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
NCT06587828
Ankylosing Spondylitis, Ankylosis
Orange, California, United States
View Trial DetailsABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
NCT05507203
Colitis, Colitis, Ulcerative
Dothan, Alabama, United States
View Trial DetailsABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
NCT05507216
Colitis, Colitis, Ulcerative
Birmingham, Alabama, United States
View Trial Details